Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 10trametinib 7Nivolumab 7selpercatinib 6pembrolizumab 6dabrafenib 6Iodine-131 6Specimen Handling 5Biopsy 5lenvatinib 4Vemurafenib 4Iodine-124 4durvalumab 3cabozantinib 3binimetinib 3Ipilimumab 3Immunoglobulin G 3Fluorodeoxyglucose F18 3Disulfides 3Cyclophosphamide 3Cetuximab 3vandetanib 2ulixertinib 2omipalisib 2larotrectinib 2defactinib 2copanlisib 2cemiplimab 2anlotinib 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Postoperative Period × 1 year × Clear all
NCT01709292 2026-04-16

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
24 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡